Quantitative Measurement of Microvascular Permeability in Human Brain Tumors Achieved Using Dynamic Contrast-enhanced MR Imaging: Correlation with Histologic Grade

References

1. ↵
   Hirata A, Baluk P, Fujiwara T, McDonald DM. Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy. Am J Physiol 1995;269:L403-418

   Abstract/FREE Full Text
2. Nugent LJ, Jain RK. Extravascular diffusion in normal and neoplastic tissues. Cancer Res 1984;44:238-244

   Abstract/FREE Full Text
3. Jain RK, Gerlowski LE. Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol 1986;5:115-170

   PubMed
4. ↵
   Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990;9:253-266

   CrossRefPubMedWeb of Science
5. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74

   PubMed
6. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71

   PubMed
7. ↵
   van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198:813-818

   PubMedWeb of Science
8. Schwickert HC, Stiskal M, Roberts TP, et al. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 1996;198:893-898

   PubMed
9. ↵
   Gossmann A, Okuhata Y, Shames DM, et al. Prostate cancer tumor grade differentiation by dynamic contrast-enhanced MR imaging: comparison of macromolecular and small-molecular contrast media. Radiology (in press)
10. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998;171:941-949

    PubMedWeb of Science
11. ↵
    Pham CD, Roberts TP, van Bruggen N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 1998;16:225-230

    CrossRefPubMedWeb of Science
12. ↵
    Gossmann A, Ostrowitzki S, Helbich T, et al. Effects of anti-VEGF antibody on malignant gliomas assessed by dynamic contrast enhanced MRI. In: Proceedings of International Society of Magnetic Resonance in Medicine: Sydney, Australia, 1998. International Society of Magnetic Resonance in Medicine; 1998:370
13. ↵
    Schwickert HC, Roberts TP, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34:845-852

    PubMed
14. ↵
    Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90

    PubMedWeb of Science
15. ↵
    Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571

    PubMedWeb of Science
16. ↵
    Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101

    CrossRefPubMedWeb of Science
17. ↵
    Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging, 1: fundamental concepts. Magn Reson Med 1991;17:357-367

    CrossRefPubMedWeb of Science
18. ↵
    Shames DM, Kuwatsuru R, Vexler V, Mühler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993;29:616-622

    CrossRefPubMed
19. Patlak CS, Goldstein DA, Hoffman JF. The flow of solute and solvent across a two-membrane system. J Theor Biol 1963;5:426-442

    CrossRefPubMedWeb of Science
20. Patlak CS, Blasberg RG, Fenstermacher JD. Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7

    CrossRefPubMedWeb of Science
21. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-242

    PubMedWeb of Science
22. ↵
    Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995;36:520-528

    PubMed
23. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299

    PubMedWeb of Science
24. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238

    PubMedWeb of Science
25. ↵
    Lammertsma A, Wise R, Jones T. In vivo measurements of regional cerebral blood flow and blood volume in patients with brain tumours using positron emission tomography. Acta Neurochir 1983;69:5-13

    CrossRefPubMed
26. ↵
    Black K, Emerick T, Hoh C, Hawkins R, Mazziotta J, Becker D. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 1994;16:93-96

    PubMed
27. ↵
    Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of ²⁰¹Tl SPECT vs ¹⁸F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163:1459-1465

    PubMed
28. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47-52
29. Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965-969

    Abstract/FREE Full Text
30. Vertosick FT, Selker RG, Grossman SJ, Joyce JM. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 1994;1994:396-401
31. ↵
    Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997;86:22-27

    PubMedWeb of Science
32. ↵
    Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174

    CrossRefPubMedWeb of Science
33. Rosen BR, Belliveau JW, Aronen H, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
34. Kucharczyk J, Roberts T, Moseley ME, Watson A. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders. J Magn Reson Imaging 1993;3:241-245

    CrossRefPubMed
35. Kucharczyk J, Vexler ZS, Roberts TP, et al. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 1993;188:711-717

    PubMedWeb of Science
36. ↵
    Perman WH, Gado MH, Larson KB, Perlmutter JS. Simultaneous MR acquisition of arterial and brain signal-time curves. Magn Reson Med 1992;28:74-83

    PubMedWeb of Science
37. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736

    CrossRefPubMedWeb of Science
38. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725

    CrossRefPubMedWeb of Science
39. ↵
    Hackländer T, Reichenbach JR, Mödder U. Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors. J Comput Assist Tomogr 1997;21:857-866

    CrossRefPubMed
40. Hackländer T, Hofer M, Reichenbach JR, Rascher K, Fürst G, Mödder U. Cerebral blood volume maps with dynamic contrast-enhanced T1-weighted FLASH imaging: normal values and preliminary clinical results. J Comput Assist Tomogr 1996;20:532-539

    CrossRefPubMed
41. Petrella JR, Wong J, Provenzale JM. False positive cerebral blood volume maps: a potential pitfall in evaluation of monoclonal antibody-treated gliomas. In: Proceedings of Joint Meeting of the ASNR, ASHNR, ASPNR, ASITN, ASSR: San Diego, CA, 1999. Oak Brook, IL: American Society of Neuroradiology;1999:59
42. Roberts HC, Saeed M, Roberts TP, et al. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability. J Magn Reson Imaging 1997;7:331-338

    PubMed
43. Brix G, Semmler W, Port R, Schad L, Layer G, Lorenz W. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628

    CrossRefPubMedWeb of Science
44. ↵
    Su MY, Najafi AA, Nalcioglu O. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995;34:402-411

    PubMedWeb of Science
45. ↵
    Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-568

    PubMedWeb of Science
46. ↵
    Wong ET, Jackson EF, Hess KR, et al. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 1998;50:777-781

    Abstract/FREE Full Text
47. ↵
    Russel D, Rubinstein L. Tumors of central neuroepithelial origin. In: Pathology of Tumours of the Nervous System. Baltimore: Williams & Wilkins; 1989;83
48. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479-1486

    CrossRefPubMedWeb of Science